Mostrando 2 resultados de: 2
Filtros aplicados
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD
ArticleAbstract: The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased drastically due to the globPalabras claves:AAV, CPT1A, fatty-acid oxidation, Gene therapy, hepatic steatosis, lipid biomarker, obesityAutores:Alonso S., Bartrons R., Calderón-Domínguez M., Casals N., Casas J., Escolà-Gil J.C., Frühbeck G., Fucho R., Herrero L., Llorente-Cortes V., Mera P., Mir J.F., Montironi C., Rodríguez A., Salvador J., Sánchez-Infantes D., Sandra Recalde, Sebastián D., Serra D., Soler-Vázquez M.C., Valentí V., Weber M., Zorzano A.Fuentes:scopusThe role of ATP-binding cassette transporter genes in the metastatic process of epithelial thyroid carcinoma with aggressive behavior
Book PartAbstract: There is a strong association between the increased expression of ATP-binding cassette (ABC) transpoPalabras claves:ATP-binding cassette transporters, BRAF gene, EMT process, Metástasis, Sodium/iodide symporter, Thyroid carcinomaAutores:Corcoy R., Enma Verónica Páez-Espinosa, Escolà-Gil J.C., Fuste V., Julve J., Lerma E., Mato E., Moral A., Pérez J.I., Revilla G.Fuentes:scopus